Patent ID: 6908897

Claim:
An insulin analogue consisting of two identical or different insulin monomers covalently linked together via a bridge. wherein the insulin, monomers are selected from a group consisting of human insulin, an animal insulin a derivative of a human insulin, and a derivative of an animal insulin, wherein at least one derivative of a human insulin or a derivative of an animal insulin is present in said insulin analogue, wherein said insulin analogue has a formula of: wherein: a) X is, independently of one another, a branched or unbranched C 1 -C 10 -alkyl group, a mono- or polysubstituted aryl group, a C 1 -C 10 -alkyl group, mono- or polysubstituted or unsubstituted O-aryl group, an amino acid, or a group of the formula NRR′, wherein b) each of R and R′ is H, NH 2 , a branched or unbranched C 1 -C 10 -alkyl radical, or a mono- or polysubstituted or unsubstituted aryl group, and wherein c) n is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, or 16; or a physiologically acceptable salt or said insulin analogue.